vzw NET & MEN Kanker retweeted
#Generalpractitioners and #endocrinologists can suspect genetic NETs most often. Awareness is needed to detect them through psychosomatic symptoms.
✅Find information in #NETInfo in 10 languages: incalliance.org/net-info-pac… #LetsTalkAboutNETs #OncTwitter #EndoTwitter #PathTwitter
vzw NET & MEN Kanker retweeted
🎯INCA equips NET patients with NET #clinicaltrials knowledge and data across the globe.
✅Check out our website for insightful guidance form prominent NET experts and search for the clinical trial that fits your condition: incalliance.org/find-a-trial…
#LetsTalkAboutNETs #EndoTwitter
vzw NET & MEN Kanker retweeted
Dr. Gerlof Valk @UMCUtrecht illustrates the shocking heterogeneity of neuroendocrine tumors, presenting near-identical cases at time of diagnosis with rapidly divergent outcomes after PRRT
A true unmet need in oncology is image-guided precision medicine
#WorldMEN2023
vzw NET & MEN Kanker retweeted
@DerksJules showing how the molecular subtypes in lung #NETs as defined by @nl_alcala can be easily identified and their impact in clinical practice. Let’s keep translating basic research as quickly as possible thanks to collaborations initiated at #ENETS2023!
vzw NET & MEN Kanker retweeted
8 Antwerpse en Wase ziekenhuizen erkend als excellentiecentrum behandeling neuro-endocriene kanker despecialist.eu/nl/nieuws/8-…
vzw NET & MEN Kanker retweeted
#EuropeanHormoneDay is back! On 15 May we invite you to join us in raising awareness of the importance of good hormone health + promote better policies for endocrine patients. Follow using #BecauseHormonesMatter + visit europeanhormoneday.org for details.
vzw NET & MEN Kanker retweeted
👉Opportunity for HCPs to get updates on generic syndromes in NEN:
✅Check out the ENETS webinar on April 19th: enets.org/webinars-podcasts.…
ENETS webinars are free of charge and videos are available on the website.
#LetsTalkAboutNETs #EndoTwitter #OncTwitter #MedTwitter
vzw NET & MEN Kanker retweeted
Neuroendocrine cancer is challenging to diagnose. 👉We would like to help all #oncologists to gain better understanding of NETs.
✅Download #NETInfo on different NETs in your language to be aware: incalliance.org/net-info-pac…
#LetsTalkAboutNETs #OncTwitter #OncoTwitter #MedTwitter
vzw NET & MEN Kanker retweeted
📢Today is #NETCancerDay! Created by INCA over 10 years ago, #NETCancerDay is held to raise awareness and improve NET diagnostics and care. Know the Symptoms. Push for Diagnosis! 📌Join us and spread the word: ▶incalliance.org/ncd-2022/ #LetsTalkAboutNETs #MedTwitter #OncoTwitter
vzw NET & MEN Kanker retweeted
9 Days to #NETCancerDay 2022! Are you getting ready to join the global NET community in raising awareness of NETs and improving the time of diagnosis? Get involved with our wealth of campaign resources: ▶incalliance.org/ncd-2022/#Le… #MedTwitter #OncoTwitter #GITwitter #MedEd
vzw NET & MEN Kanker retweeted
Don’t miss the chance to join this year’s ENETS-INCA #NETCancerDay Educational Webinar on November 10th, from 12:00 to 14:15 CET, get updates from top NET experts and INCA patient leaders. Read more: ➡️https://teapawt.org/t.co/I8RYGtphyz #LetsTalkAboutNETs #MedTwitter #OncoTwitter #GITwitter
vzw NET & MEN Kanker retweeted
NET patients spend 90% at home - importance of support services by patient organizations was highlighted and practical tips for partnering with medical community – from Catherine Bouvier, CEO @ncukcharity, and Simone Leyden, CEO, @NECancerAus. #LetsTalkAboutNETs #MedTwitter
vzw NET & MEN Kanker retweeted
#2022INCASummit: Poorly differentiated NEC trials and adoptive immunotherapy are the areas of need for study – highlighted by Prof. Jon Strosberg, NANETS President, in the session focused on Research and Clinical Trials. Thank you! #LetsTalkAboutNETs #MedTwitter #OncoTwitter
vzw NET & MEN Kanker retweeted
At 2022 INCA Summit: Delving into QoL Studies and clinical trials that matter to the patients - with internationally recognized advocate Josh Mailman alerting on the new clinical trials search tools that can be easy to use by NET patients. #LetsTalkAboutNETs #MedTwitter
vzw NET & MEN Kanker retweeted
INCA Global NET patient advocates summit 2022 kicks off with opening remarks by President Mark McDonnell and Exec Director Teodora Kolarova
#LetsTalkAboutNETs
vzw NET & MEN Kanker retweeted
Over 650 buildings around the world lit up for #RareDiseaseDay on 28 February!
Together we lit up the night sky to show the world our colours and raise awareness for the rare disease community.💙 💜 💚
Take a look at some of our favourite illuminations from this year! 👀
vzw NET & MEN Kanker retweeted
PRRT now officially refunded by the social security system in Belgium. Congratulations to our member @NETenMENkanker Belgium for their successful advocacy efforts! Find out more: incalliance.org/prrt-now-off… #LetsTalkAboutNETs
vzw NET & MEN Kanker retweeted
Replying to @drenriquegrande
@drenriquegrande makes the powerful point that the time to diagnosis for our patients is unacceptable and would not be accepted in any other cancer field #enets2022 #Neuroendocrine
vzw NET & MEN Kanker retweeted
Eric Baudin on the educational work #enets2022 is undertaking to inform healthcare professionals and patients/caregivers about NENs. Over 15 webinars to date and +7800 views. Work to continue including collaboration with the ENETs nurse/ @BDA_Dietitians and INCA @CancerLead
vzw NET & MEN Kanker retweeted
INCA’s Executive Director, Teodora Kolarova presenting at the #enets2022 Nurse Sumposium on INCA NET Nurse Info Packs. Multi lingual resources available across the globe @TeodoraINCA #LetsTalkAboutNETs @NurseinPractice































